Biotech

All Articles

Aelis' cannabis make use of medicine fails period 2b, driving Indivior to reassess $100M option

.Aelis Farma's hopes of getting a simple, positive selection on a $one hundred thousand alternative ...

ProKidney halts period 3 trial certainly not needed to have for cell treatment permission

.ProKidney has stopped among a set of period 3 tests for its cell therapy for kidney disease after c...

Vaxcyte rises on 'sensational' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what analysts referred to as "magnificent" phase 1/2 records for its own 31-valent...

Recursion's human brain illness test shows insufficient evidence of effectiveness

.Recursion has actually stumbled with an early examination of its own tech-enabled method to medicin...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Phone it a scenario of great chemistry: Acepodia, a biotech based on Nobel Prize-winning scientific...

Praxis epilepsy medicine decreases seizures in phase 2 litigation

.Practice Preciseness Medicines has scored one more midphase gain in epilepsy this year, along with ...

Three execs resign as Dyne articles mixed data for DMD prospect

.After escaping a clinical grip several years back, Dyne Rehab has actually exposed brand-new stage ...

Arrowhead fires off period 3 information in uncommon metabolic health condition in front of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its hand ahead of a possible face-off with Ionis, post...

Pfizer, Valneva show lyme health condition try helpful for second booster

.Pfizer as well as Valneva may have about 2 additional years to stand by before they make the first ...

Fierce Biotech Managing Editor Ayla Ellison Speaks Patronize Michelle Benz on the Future of Biotech.

.Permit's dive into a discussion along with Ayla Ellison, Intense Biotech Editor-in-Chief as well as...